Related Experiment Video
Updated: Jun 7, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
The patient perspective on the environmental impact of inhalers
Alexandra Hodge1, Helena Wickham1, Katia Florman1
1Respiratory Medicine Department, Royal Free and Barnet Hospitals, Royal Free NHS Foundation Trust, Pond Street, London, England, NW3 2QG, UK.
Introduction:
Increasing the proportion of low-carbon inhalers prescribed within the NHS forms a central part of net-zero policy. Yet, the patients' perspective on this strategy has not been determined. We aimed to establish if environmental issues are important to respiratory patients and whether this may influence inhaler choice.
Methods:
We conducted a survey of 61 respiratory patients at the Royal Free NHS Foundation Trust, London to establish their perspective on the environmental impact of inhalers.
Results:
We identified that 70.5 % (43/61) of patients did not know that inhalers could contribute to climate change. Furthermore, 85.3 % (52/61) of patients felt it was 'quite' or 'very important' to reduce their own contribution to climate change. Importantly, 59 % (36/61) of patients would actively want to change inhalers and 26.2 % (16/61) would consider changing inhalers based on this information. There was no significant difference based on age (< or ≥ 60 years) (Chi2 = 1.2, p = 0.28) or gender (Chi2 = 0.88, p = 0.77).
Discussion:
These findings demonstrate that environmental issues are important to respiratory patients. Despite this, the environmental impact of inhalers is not routinely discussed with patients. Once provided with this information patients actively want to change to low-carbon inhalers. Hence, the environmental impact of inhalers should be shared with patients to help us to achieve a net-zero NHS.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-III: Symptoms and Complications
Classification of Asthma

